CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease [Phase 2]
Summary
Phase 2 clinical trial investigating inhaled mometasone to reduce painful episodes in sickle cell disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jeffrey Glassberg | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-03-11